"The Cardiovascular Research Foundation, a fundraising group for cutting-edge heart medicine, paid Clinton $275,000 for a speech in Washington in September 2014. That same year, the organization joined other medical and health care groups in urging the Federal Drug Administration to reconsider its generic labeling rules. Foundation spokeswoman Irma Damhuis said Clinton was invited as a "recognized thought leader," adding that "decisions on keynote speakers are made without a political agenda.""